Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 10364-s
2. 2-alpha,3 Alpha-epithio-5 Alpha-androstan-17 Beta-yl-1-methoxycyclopentyl Ether
1. 21362-69-6
2. Thioderon
3. O00404969k
4. (1s,3as,3br,5as,6as,7ar,8as,8bs,10as)-1-((1-methoxycyclopentyl)oxy)-8a,10a-dimethylhexadecahydro-1h-cyclopenta[7,8]phenanthro[2,3-b]thiirene
5. Mepitiostano
6. Mepitiostanum
7. Thioderon (tn)
8. Mepitiostane [inn:jan]
9. Mepitiostane [mi]
10. Mepitiostane [inn]
11. Mepitiostane [jan]
12. Mepitiostanum [inn-latin]
13. Mepitiostane (jp17/inn)
14. Mepitiostano [inn-spanish]
15. Schembl13123
16. Mepitiostane [mart.]
17. Mepitiostane [who-dd]
18. Ccris 2779
19. Chembl2104860
20. Chebi:31818
21. Dtxsid001016882
22. Unii-o00404969k
23. Zinc4216860
24. Akos015904663
25. Ncgc00522025-01
26. 10364s
27. D01602
28. S 10364
29. Q6817819
30. 2-alpha,3-alpha-epithio-17-beta-yl 1-methoxycyclopentyl Ether
31. 5-alpha-androstane, 2-alpha,3-alpha-epithio-17-beta-(1-methoxycyclopentyloxy)-
32. Androstane, 2,3-epithio-17-((1-methoxycyclopentyl)oxy)-, (2alpha,3alpha,5alpha,17beta)-
33. Cyclopentanone 2alpha,3alpha-epithio-5alpha-androstan-17beta-yl Methyl Acetal
34. Cyclopentanone, 2-alpha, 3-alpha-epithio-5-alpha-androstan-17-beta-yl Methyl Acetal
35. (1s,2s,4r,6s,8s,11r,12s,15s,16s)-15-(1-methoxycyclopentyl)oxy-2,16-dimethyl-5-thiapentacyclo[9.7.0.02,8.04,6.012,16]octadecane
36. Androstane, 2,3-epithio-17-((1-methoxycyclopentyl)oxy)-, (2-alpha,3-alpha,5-alpha,17-beta)
37. Cyclopentanone 2.alpha.,3.alpha.-epithio-5.alpha.-androstan-17.beta.-yl Methyl Acetal
| Molecular Weight | 404.7 g/mol |
|---|---|
| Molecular Formula | C25H40O2S |
| XLogP3 | 6.6 |
| Hydrogen Bond Donor Count | 0 |
| Hydrogen Bond Acceptor Count | 3 |
| Rotatable Bond Count | 3 |
| Exact Mass | 404.27490169 g/mol |
| Monoisotopic Mass | 404.27490169 g/mol |
| Topological Polar Surface Area | 43.8 Ų |
| Heavy Atom Count | 28 |
| Formal Charge | 0 |
| Complexity | 630 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 9 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Anabolic Agents
These compounds stimulate anabolism and inhibit catabolism. They stimulate the development of muscle mass, strength, and power. (See all compounds classified as Anabolic Agents.)
Antineoplastic Agents
Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)
Estrogen Antagonists
Compounds which inhibit or antagonize the action or biosynthesis of estrogenic compounds. (See all compounds classified as Estrogen Antagonists.)
ABOUT THIS PAGE
A Mepitiostane manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Mepitiostane, including repackagers and relabelers. The FDA regulates Mepitiostane manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Mepitiostane API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Mepitiostane supplier is an individual or a company that provides Mepitiostane active pharmaceutical ingredient (API) or Mepitiostane finished formulations upon request. The Mepitiostane suppliers may include Mepitiostane API manufacturers, exporters, distributors and traders.
click here to find a list of Mepitiostane suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Mepitiostane Drug Master File in Japan (Mepitiostane JDMF) empowers Mepitiostane API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Mepitiostane JDMF during the approval evaluation for pharmaceutical products. At the time of Mepitiostane JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Mepitiostane suppliers with JDMF on PharmaCompass.
Mepitiostane Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Mepitiostane GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Mepitiostane GMP manufacturer or Mepitiostane GMP API supplier for your needs.
A Mepitiostane CoA (Certificate of Analysis) is a formal document that attests to Mepitiostane's compliance with Mepitiostane specifications and serves as a tool for batch-level quality control.
Mepitiostane CoA mostly includes findings from lab analyses of a specific batch. For each Mepitiostane CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Mepitiostane may be tested according to a variety of international standards, such as European Pharmacopoeia (Mepitiostane EP), Mepitiostane JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Mepitiostane USP).
LOOKING FOR A SUPPLIER?
